| 25.37 1.25 (5.18%) | 07-27 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 36.96 | 1-year : | 42.58 |
| Resists | First : | 31.64 | Second : | 36.45 |
| Pivot price | 25.73  |
|||
| Supports | First : | 23.87 | Second : | 19.85 |
| MAs | MA(5) : | 24.75 |
MA(20) : | 26.79 |
| MA(100) : | 28.17 |
MA(250) : | 0 | |
| MACD | MACD : | -1.6 |
Signal : | -1.5 |
| %K %D | K(14,3) : | 16.1 |
D(3) : | 10.6 |
| RSI | RSI(14): 42.5 |
|||
| 52-week | High : | 41.22 | Low : | 20.12 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HTFL ] has closed above bottom band by 41.9%. Bollinger Bands are 38.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 25.67 - 25.79 | 25.79 - 25.9 |
| Low: | 23.96 - 24.1 | 24.1 - 24.22 |
| Close: | 25.16 - 25.38 | 25.38 - 25.57 |
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Mon, 20 Jul 2026
Frontier tech research, news & data - MLQ.ai
Fri, 17 Jul 2026
Heartflow CMO Rogers Campbell sells $237,112 in stock By Investing.com - Investing.com Nigeria
Fri, 17 Jul 2026
Heartflow (HTFL) CMO option exercise and 9,219-share sale under 10b5-1 plan - Stock Titan
Thu, 16 Jul 2026
Heartflow, Inc. Common Stock (NASDAQ: HTFL) Stock Price, News & Analysis - Kalkine
Wed, 15 Jul 2026
Campbell D. Rogers plans 9,219-share HTFL stock sale on NASDAQ - Stock Titan
Fri, 10 Jul 2026
HTFL (NASDAQ: HTFL) holder lines up $626K July 10 share sale - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 86 (M) |
| Shares Float | 66 (M) |
| Held by Insiders | 5.1 (%) |
| Held by Institutions | 79.3 (%) |
| Shares Short | 5,870 (K) |
| Shares Short P.Month | 4,210 (K) |
| EPS | -3.09 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.31 |
| Profit Margin | -58.5 % |
| Operating Margin | -41.9 % |
| Return on Assets (ttm) | -16.3 % |
| Return on Equity (ttm) | -135.4 % |
| Qtrly Rev. Growth | 41.2 % |
| Gross Profit (p.s.) | 1.73 |
| Sales Per Share | 2.21 |
| EBITDA (p.s.) | -0.78 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -71 (M) |
| Levered Free Cash Flow | -49 (M) |
| PE Ratio | -8.22 |
| PEG Ratio | 0 |
| Price to Book value | 7.64 |
| Price to Sales | 11.42 |
| Price to Cash Flow | -30.84 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|